Ozempic and other glucagon-like peptide-1 (GPL-1) agonist medications accounted for 10% of the state employee health plan’s ...

Learn more about the metabolic effects of liraglutide treatment in individuals with type 2 diabetes and obesity.

Former *NSYNC star Lance Bass discussed how his Type 1.5 diabetes was misdiagnosed and the importance of knowing your blood ...

Metformin and GLP-1 receptor agonists significantly reduce asthma attacks in patients with type 2 diabetes, offering ...

One of the biggest obstacles to Ozempic accessibility is cost. If you’re paying for the GLP-1 drug out of pocket, the list ...

A genetic predisposition to having lower insulin production and less healthy fat distribution are major causes of early-onset ...

Tirzepatide, a new injectable weight-loss drug with the trade name Zepbound, reduced the risk of diabetes in patients with obesity and prediabetes by ...

GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...

Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical ...

After visiting several doctors and looking at several months of his blood glucose trends, Bass learned he had Type 1.5 ...

A genetic predisposition to having lower insulin production and less healthy fat distribution are major causes of early-onset ...